Skip to main content
Premium Trial:

Request an Annual Quote

Congenica Raises $3.3M in Series A Financing

NEW YORK (GenomeWeb) – Cambridge, UK-based Congenica today announced it has raised £2.2 million ($3.3 million) in Series A financing from Amadeus Capital Partners and Cambridge Innovation Capital.

The firm has developed Sapientia, a platform to screen whole-genome sequencing data to identify novel genetic mutations and highlight those associated with genetic disorders.

Congenica, a spinout of The Wellcome Trust Sanger Institute, will use the funds to further develop its technology, the firm said in a statement.

"We have an excellent investor base and have now achieved £5 million in funding and grants and which will help us take the technology into the clinic and accelerate our growth," Congenica CEO Tom Weaver said in a statement.

In March, Congenica received a share of £8 million in research grants awarded by Genomics England to improve genomic data analysis.